Dr. Shamir Shmuel Geller, MD

Dr. Geller practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Geller's NPI, 1992259154, was assigned on August 5, 2016. Dr. Geller graduated from Tel Aviv University Sackler in 2011. Dr. Geller holds New York license 299177.

Dr. Geller's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Geller's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Dermatology Group. Dmand AI also links Dr. Geller to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Geller practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Geller's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Geller's licenses on file in 2 states: New York and Florida.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, rash and scalp rash among the conditions Dr. Geller treats.

CMS data shows 661 Medicare services from Dr. Geller across 8 procedure codes in 2024, for 285 Medicare patients. Medicare paid $52,377 for them.

CMS counts 285 Medicare patients who saw Dr. Geller in 2024. The largest group is 65 to 74, with 131 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Geller's median patient age at 69, with 45% women.

In 2024, Dr. Geller wrote 608 Medicare Part D claims for 172 patients. 95% of them were for generic drugs. CMS names the drug for 488 of them, across 12 drugs with 11 or more claims each, at $15,671 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Geller for performance year 2024, reported as part of a group. Dr. Geller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Geller as offering telehealth. CMS counts 67 procedures of skin biopsy by Dr. Geller, more than 71% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 54 papers to Dr. Geller, published from 2014 to 2025. 2018 was the busiest year, with 9. The most frequent topics are Skin Neoplasms, Mycosis Fungoides and Lymphoma, T-Cell, Cutaneous. Dr. Geller has published most often in J Am Acad Dermatol. Dr. Geller's most frequent co-authors are Patricia L. Myskowski, MD, Eli Sprecher, MD and Melissa P. Pulitzer, MD.

CMS Open Payments shows 3 general payments to Dr. Geller from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Secura Bio, Inc. paid the most, $179.

Dr. Geller graduated from Tel Aviv University Sackler in 2011.

Dr. Geller is in network with 5 carriers, including Excellus BlueCross BlueShield, MVP Health Care and Aetna. EPO plans come from the most carriers, 2. Check the plan with the practice before a visit.